iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice
International Immunopharmacology · 2026-07 · 181 · 116750
DOI: 10.1016/j.intimp.2026.116750 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-07. Verfasst von Pan Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China; Tia…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Nitric Oxide Synthase Type II, Skin. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Tianjin Municipal Science and Technology Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. Its pathogenesis is closely related to the imbalance of immune homeostasis regulation. Accumulating evidence demonstrated that nitric oxide (NO) serves a critical role in modulating skin immune homeostasis during the development of multiple inflammatory skin diseases. NO is mainly synthesized by inducible nitric oxide synthase (iNOS); however, the mechanism underlying iNOS in AD has not been fully elucidated yet. The present study aimed to investigate the specific mechanisms by which iNOS regulates the development of AD. METHODS We first detected the expression of iNOS in AD lesions using immunofluorescence staining. Subsequently, we detected the expression of inflammatory cytokines and chemokines using pathological staining and qRT-PCR; and assessed the infiltration of immune cells by flow cytometry and immunofluorescence staining. We utilized RNA-seq to initially explore the mechanism by which iNOS regulates AD progression. Finally, we used IL-17 A combined with TNF-α to stimulate mouse keratinocytes and fibroblasts to further validate the in vivo results. RESULTS Our results showed that iNOS expression was significantly upregulated in AD lesions, and iNOS deficiency significantly promoted the AD-like inflammation. Subsequently, the results of RNA-seq and qRT-PCR demonstrated that iNOS deficiency significantly promoted the expression of vital effector molecules of "IL-17 signaling pathway". At the same time, the proportion of IL-17 A+T cells was significantly increased in skin lesions of iNOS-deficient mice. Finally, iNOS deficiency significantly up-regulated the expression levels of multiple cytokines in keratinocytes and fibroblasts. CONCLUSION iNOS deficiency exacerbated AD-like inflammatory responses, which may be associated with increased IL-17 signaling activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China; Tianjin Pediatric Research Institute, Tianjin Key Laboratory of Birth Def…
- Department of Dermatology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China.
- Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
- College of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
- Yunnan University of Chinese Medicine, Kunming, China.
- Department of Dermatology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China. Electronic address: zbingxin@163.com.
Förderung
- Tianjin Municipal Science and Technology Program
- National Natural Science Foundation of China
Zitieren
APA
Guo, P., Cui, H., Wang, B., Shi, L., Li, F., Di, Y., Wang, S., Zhang, B., Li, X., & Hu, L. (2026). iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice. International Immunopharmacology, 181, 116750. https://doi.org/10.1016/j.intimp.2026.116750
Vancouver
Guo P, Cui H, Wang B, Shi L, Li F, Di Y, et al. iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice. International Immunopharmacology. 2026;181:116750. doi:10.1016/j.intimp.2026.116750
BibTeX
@article{Guo2026,
author = {Guo, Pan and Cui, Hong and Wang, Bingkun and Shi, Liwen and Li, Fengtong and Di, Yibo and Wang, Shuying and Zhang, Bingxin and Li, Xiaoxia and Hu, Lizhi},
title = {iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice},
journal = {International Immunopharmacology},
year = {2026},
volume = {181},
pages = {116750},
doi = {10.1016/j.intimp.2026.116750}
}
EUVIMED